Department of Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA.
Rheumatology Section, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Lupus Sci Med. 2020 May;7(1). doi: 10.1136/lupus-2020-000382.
Neutrophils contribute to the SLE pathogenesis. Neutrophil to lymphocyte ratio (NLR) is reported to correlate with disease activity in SLE. The aim of the study was to evaluate whether NLR reflects underlying immunopathogenic activity in SLE, as well as to determine the contribution of each component of NLR, neutrophil and lymphocyte count.
Data were obtained from a cohort of patients with SLE (n=141) recruited at Lund University, Sweden. NLR levels were compared between patients with SLE and healthy controls (n=79). The relationship between NLR and clinical and immunological markers was examined using Mann-Whitney U test and logistic regression analysis. High NLR was defined as above the 90th percentile of healthy individuals.
Patients with SLE had elevated neutrophil count (p=0.04) and reduced lymphocyte count (p<0.0001), resulting in elevated NLR as compared with healthy controls (p<0.0001). Patients with high NLR had more active disease, and were more frequently on prednisone use and immunosuppressive medicines. High NLR was associated with immune complex (IC)-driven disease with presence of antidouble-stranded DNA antibodies (p=0.006), circulating ICs (p=0.02) and type I interferon (IFN) activity (p=0.009). Further, high NLR was associated with neutrophil abnormalities, including enrichment for low-density granulocytes (LDGs) (p=0.001), and increased levels of the serum neutrophil activation marker, calprotectin (p=0.02). Assessing the individual components within NLR, that is, neutrophil and lymphocyte count, high neutrophil count was associated with neutrophil activation markers (p<0.0001), whereas low lymphocyte count was associated with type I IFN activity and elevated numbers of LDGs (p=0.006 and p=0.001, respectively).
NLR is elevated in patients with SLE as compared with healthy individuals, and is associated with key immunopathological events, including type I IFN activity and neutrophil activation. Neutrophil and lymphocyte count reflected different aspects of the pathogenesis of SLE. Further studies are needed to determine the causality of the associations.
中性粒细胞参与了系统性红斑狼疮(SLE)的发病机制。有报道称中性粒细胞与淋巴细胞比值(NLR)与 SLE 的疾病活动度相关。本研究旨在评估 NLR 是否反映了 SLE 中的潜在免疫发病机制活动,以及确定 NLR 的各个组成部分,即中性粒细胞和淋巴细胞计数的贡献。
数据来自于瑞典隆德大学的 SLE 患者队列(n=141)。将 SLE 患者与健康对照者(n=79)的 NLR 水平进行比较。使用 Mann-Whitney U 检验和逻辑回归分析检查 NLR 与临床和免疫标志物之间的关系。高 NLR 定义为高于健康个体第 90 百分位数。
与健康对照组相比,SLE 患者的中性粒细胞计数升高(p=0.04),淋巴细胞计数降低(p<0.0001),导致 NLR 升高(p<0.0001)。高 NLR 的患者疾病活动度更高,更频繁地使用泼尼松和免疫抑制药物。高 NLR 与免疫复合物(IC)驱动的疾病相关,存在抗双链 DNA 抗体(p=0.006)、循环 ICs(p=0.02)和 I 型干扰素(IFN)活性(p=0.009)。此外,高 NLR 与中性粒细胞异常相关,包括低密度粒细胞(LDG)富集(p=0.001)和血清中性粒细胞激活标志物钙卫蛋白水平升高(p=0.02)。评估 NLR 中的个体成分,即中性粒细胞和淋巴细胞计数,高中性粒细胞计数与中性粒细胞激活标志物相关(p<0.0001),而低淋巴细胞计数与 I 型 IFN 活性和 LDG 数量增加相关(p=0.006 和 p=0.001)。
与健康个体相比,SLE 患者的 NLR 升高,与关键的免疫病理事件相关,包括 I 型 IFN 活性和中性粒细胞激活。中性粒细胞和淋巴细胞计数反映了 SLE 发病机制的不同方面。需要进一步的研究来确定这些关联的因果关系。